新系统,老问题:高优先级移植候选者等待时间增加
本研究基于美国器官共享联合网络(UNOS)登记数据,纳入2018年10月18日至2022年7月8日所有成人单器官移植受者,按4个时期比较等待时间。研究发现9,143例中897例列为status 1,中位等待时间按血型或地区无显著变化;4,523例列为status 2,政策实施后每个后续时期与status 2平均等待时间增加4.2天相关(95%CI 3.0-5.5,p<0.0001)。
要点
- status 1候选者中位等待时间按血型或地区无显著变化。
- status 2候选者政策实施后每个后续时期平均等待时间增加4.2天(95%CI 3.0-5.5,p<0.0001)。
- O型血候选者等待时间最长,AB型与A型最短;各区域等待时间均随时间增加。
核心结论
- 2018年心脏分配政策实施后,最高优先级status 1患者的中位等待时间按血型或地区无显著变化,但status 2患者平均等待时间每个后续时期增加4.2天。
研究设计与样本
- 基于UNOS登记数据的回顾性队列研究,纳入2018年10月18日至2022年7月8日所有成人单器官移植受者,共9,143例,按4个时期分析,并按血型和UNOS地区比较结局。
主要发现
- 研究期间9,143例中897例列为status 1,中位等待时间按血型或地区无显著变化。
- 4,523例列为status 2,政策实施后每个后续时期与status 2平均等待时间增加4.2天相关(95%CI 3.0-5.5,p<0.0001)。
- status 2等待时间以O型血候选者最长,AB型与A型最短;各地区等待时间均随时间增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2018 heart allocation policy sought to improve risk stratification and reduce waitlist mortality for the sickest patients. This study sought to evaluate changes in wait times for the highest priority patients since policy implementation. All adult single-organ transplant recipients were identified in the United Network for Organ Sharing registry from October 18, 2018, to July 8, 2022, and separated into 4 periods. Outcomes were compared by blood type and UNOS region. Over the study period, 897 of 9,143 patients were listed as status 1 with no significant change in median wait time by blood type or region. More patients were listed as status 2 (4,523/9,143), and each subsequent period postpolicy change was associated with a 4.2-day increase in mean status 2 waitlist time (95% confidence interval 3.0-5.5, p < 0.0001). Wait times were longest for candidates with blood type O and shortest for AB & A. Regional variations continued, however, wait time increased in every region over time.
引用
- Harris E, Sewanan L, Topkara VK, et al. New system, old problem: Increased wait time for high-priority transplant candidates. J Heart Lung Transplant. 2023. PMID: 37506955. doi:10.1016/j.healun.2023.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。